Investor Relations

NattoPharma's principal shareholder policy is to maximize returns earned by its shareholders over time and we strive to protect our shareholders' investments.

NattoPharma is committed to provide the financial market and other interested parties with correct, consistent and relevant information in order to enhance the understanding of the company. Thus ensuring that the value assessment of NattoPharma's underlying value and future growth prospects is formed on the best possible basis.

NattoPharma ASA was admitted to the Oslo Stock Exchange list "Oslo Axess" as per January 30th 2008. The ticker name is NATTO.

Please use the menu on the left or visit our profile on the Oslo Stock Exchange.

Contact Us

For more information, please visit our profile on the Oslo Stock Exchange website or contact:

Kjetil Ramsøy
Tel: (+47) 906 12 943

NattoPharma contact information:
Main office: Lilleakerveien 2B, 0283 Oslo,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+47) 40 00 90 08
Tel: (+1) 609-454-2992
Created by:
Nutricon logo.
Search term: